Skip to content
Disclosery

13F-HR filed by Pennant Investors, LP

Pennant Investors, LP filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 44 holding rows worth $458,081,389.

Accession
0000919574-24-001300
Filer
CIK 1759176
Filed
2024-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2023

A holdings report, 46 entries on the cover page, a total value of $458,081,389 stated on the cover page (in dollars after the unit check, H1), rows summing to $458,081,389 with VALUE read as dollars as filed, 13F file number 028-18953. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Apple Inc037833100COM630,000$121,293,900dollars as filedput
Amazon.com, Inc023135106COM348,000$52,875,120dollars as filed
Alphabet Inc. Reg. Shares A02079K305COM375,000$52,383,750dollars as filed
Microsoft Corp594918104COM129,000$48,509,160dollars as filed
TRANSDIGM GROUP INC COM893641100Stock42,000$42,487,200dollars as filed
ECHOSTAR CORP278768106CL A2,153,209$35,678,673dollars as filed
Micron Technology,Inc.595112103COM306,000$26,114,040dollars as filed
THE ODP CORP88337F105COM400,000$22,520,000dollars as filed
ANTERO RESOURCES CORP COM03674X106Stock913,000$20,706,840dollars as filed
ANTERO RESOURCES CORP COM03674X106Stock500,000$11,340,000dollars as filedcall
PERIMETER SOLUTIONS SAL7579L106COMMON STOCK-FO2,300,000$10,580,000dollars as filed
ALTIMMUNE INC02155H200COM NEW109,800$1,235,250dollars as filed
FIBROGEN INC31572Q808COM768,400$681,033dollars as filed
NURIX THERAPEUTICS INC67080M103COMMON STOCK56,800$586,176dollars as filed
COHERUS ONCOLOGY INC19249H103COM168,100$559,773dollars as filed
ARCUTIS BIOTHERAPEUTICS INC03969K108COM170,900$552,007dollars as filed
FATE THERAPEUTICS INC31189P102COM146,100$546,414dollars as filed
IGM BIOSCIENCES INC449585108COM64,900$539,319dollars as filed
ALLAKOS INC01671P100COM186,100$508,053dollars as filed
TRAVERE THERAPEUTICS INC89422G107COM55,800$501,642dollars as filed
89BIO INC282559103COM44,500$497,065dollars as filed
ZENTALIS PHARMACEUTICALS INC98943L107COMMON STOCK32,400$490,860dollars as filed
RELAY THERAPEUTICS INC COM75943R102Stock42,400$466,824dollars as filed
ARCUS BIOSCIENCES INC03969F109COM23,700$452,670dollars as filed
MACROGENICS INC556099109COM43,800$421,356dollars as filed
ARCTURUS THERAPEUTICS HLDGS03969T109COM13,100$413,043dollars as filed
ALLOGENE THERAPEUTICS INC019770106COM128,400$412,164dollars as filed
SERES THERAPEUTICS INC81750R102COM292,300$409,220dollars as filed
ZYMEWORKS INC98985Y108COM38,700$402,093dollars as filed
AGENUS INC00847G705COM NEW469,600$388,782dollars as filed
SAGE THERAPEUTICS INC78667J108COM17,500$379,225dollars as filed
ERASCA INC COM29479A108Stock166,200$354,006dollars as filed
AGIOS PHARMACEUTICALS INC00847X104COM15,100$336,277dollars as filed
ENANTA PHARMACEUTICALS INC29251M106COM35,100$330,291dollars as filed
UNIQURE NVN90064101SHS48,500$328,345dollars as filed
GETAROUND INC37427G101COM1,348,153$316,816dollars as filed
COMPASS THERAPEUTICS INC20454B104COM199,000$310,440dollars as filed
NOVAVAX INC670002401COM NEW60,300$289,440dollars as filed
REPLIMUNE GROUP INC76029N106COMMON STOCK30,500$257,115dollars as filed
BIOXCEL THERAPEUTICS INC09075P105COM83,900$247,505dollars as filed
ALLOVIR INC019818103COM215,700$146,633dollars as filed
BLUEBIRD BIO INC09609G100COM87,400$120,612dollars as filed
AIRSPAN NETWORKS HOLDINGS IN00951K104COM1,047,473$94,273dollars as filed
GRAB HOLDINGS LIMITEDG4124C117*W EXP 99/99/99980,000$17,984dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-24-001300this filing2024-02-14acceptance time not in the bulk data set